SOTIO Biotech is an innovative, clinical-stage biopharmaceutical company developing targeted cancer therapies with first-in-class and best-in-class potential. Our pipeline features a portfolio of next generation mono- and bispecific antibody–drug conjugates (ADCs) as well as a PD-1 cis-targeted IL-15 immunocytokine designed to overcome key limitations of current immuno-oncology approaches.
Address
PraguePrague
Czech Republic
